The UK's Prescription Medicines Code of Practice Authority, which enforces the Association of the British Pharmaceutical Industry's marketing rules, has reported a small reduction in the number of complaints about the promotion of prescription drugs, from 128 in 2006 to 122 last year. Violations of the Code were ruled in 61% or less of cases considered in 2007 and 2006. This compares favorably with 2005 where 80% of the 107 complaints were upheld. There was also a decrease in time taken to consider cases in 2007 compared with 2006.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze